These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2932859)

  • 21. [The administration of thrombolytic agents in peripheral vascular occlusion].
    Buth J
    Ned Tijdschr Geneeskd; 1988 Sep; 132(39):1785-9. PubMed ID: 3054574
    [No Abstract]   [Full Text] [Related]  

  • 22. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
    Marder VJ; Francis CW
    Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
    [No Abstract]   [Full Text] [Related]  

  • 23. Biochemical and clinical aspects of thrombolysis.
    Verstraete M
    Semin Hematol; 1978 Jan; 15(1):35-54. PubMed ID: 341327
    [No Abstract]   [Full Text] [Related]  

  • 24. [Local low dosage, fibrinolytic therapy: indications, technic and results].
    Roth FJ; Krings W; Cappius G; Schmidtke I; Köhler M
    Vasa Suppl; 1984; 12():52-8. PubMed ID: 6237510
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment with the urokinase-lysyl plasminogen combination of developmental outbreaks of arteriopathies].
    Vitoux JF; Roncato M; Pernes JM; Fiessinger JN; Aiach M; Gaux JC
    Ann Med Interne (Paris); 1986; 137(2):105-7. PubMed ID: 3717814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraarterial fibrinolytic therapy for popliteal and tibial artery obstruction: comparison of streptokinase and urokinase.
    Traughber PD; Cook PS; Micklos TJ; Miller FJ
    AJR Am J Roentgenol; 1987 Sep; 149(3):453-6. PubMed ID: 3497528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Laboratory control of fibrinolytic therapy].
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):30-7. PubMed ID: 2427412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Possibilities and limitations of local thrombolysis of peripheral arterial occlusions].
    Fischer M
    Med Klin (Munich); 1987 Jun; 82(12-13):434-8. PubMed ID: 2956492
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thrombolytic treatment of arteriopathies. Do thrombolytics compete with surgery?].
    Fiessinger JN; Aiach M; Vitoux JF; Pernes JM; Roncato M; Gaux JC
    Haemostasis; 1986; 16 Suppl 4():87-9. PubMed ID: 3770561
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrinolysis--a review.
    Kane KK
    Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of urokinase and tissue-type plasminogen activator in transcatheter arterial fibrinolysis].
    Vignali C; Cioni R; Mascalchi M; Russo R; Palla A; Lencioni R; Napoli V; Bartolozzi C
    Radiol Med; 1994; 88(1-2):93-9. PubMed ID: 8066262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of the fibrinolytic system in the newborn].
    Schlegel N; Hurtaud-Roux MF; Beaufils F
    Ann Pediatr (Paris); 1993 Feb; 40(2):70-4. PubMed ID: 8457135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombolytic therapy and its combination with transluminal catheter dilatation.
    Hess H
    Wien Klin Wochenschr; 1985 Jan; 97(2):61-4. PubMed ID: 3157270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local low-dose thrombolysis in arterial disease of the limbs.
    Verhaeghe R; Wilms G; Vermylen J
    Semin Thromb Hemost; 1987 Apr; 13(2):206-11. PubMed ID: 2957792
    [No Abstract]   [Full Text] [Related]  

  • 37. Fibrinolytic therapy.
    Persson AV; Padberg FT; Dyer VE
    Compr Ther; 1980 Nov; 6(11):12-7. PubMed ID: 7438726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological profile of the 1st 4 hours of a thrombolytic treatment combining urokinase with lysyl-plasminogen].
    Roncato M; Vitoux JF; Pernes JM; Aiach M; Fiessinger JN; Gaux JC; Housset E; Leclerc M
    Ann Biol Clin (Paris); 1985; 43(6):851-5. PubMed ID: 3832977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemostasis and fibrinolysis in patients with intermittent claudication: effects of prostaglandin E1.
    Weiss C; Regele S; Velich T; Bärtsch P; Weiss T
    Prostaglandins Leukot Essent Fatty Acids; 2000 Nov; 63(5):271-7. PubMed ID: 11090253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential treatment of arterial occlusions with porcine plasmin and low dose streptokinase.
    Marbet GA; Eichlisberger R; Duckert F; da Silva MA; Biland L; Widmer LK; Ritz R; Schmitt HE
    Thromb Haemost; 1982 Oct; 48(2):187-9. PubMed ID: 6217580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.